Investigational New Drug (IND) Application

From GM-RKB
Jump to navigation Jump to search

An Investigational New Drug (IND) Application is a limited clinical investigation program that has been approved by the U.S. Food and Drug Administration to start human clinical trials for the purpose of researching and testing a new pharmaceutical drug.



References

2022a

2022b

There are two IND categories: